Warszawa, Mazowieckie, Poland National Center for Research & Development is the famous Corporate Investor, which was founded in 2007. The venture was found in Europe in Poland. The main office of represented Corporate Investor is situated in the Warszawa.
The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the National Center for Research & Development, startups are often financed by EASME - EU Executive Agency for SMEs, Boost VC, Black Pearls VC. The meaningful sponsors for the fund in investment in the same round are European Commission. In the next rounds fund is usually obtained by ff Venture Capital, Techstars, RTAventures VC.
The top activity for fund was in 2017. Despite it in 2019 the fund had an activity. The increased amount of exits for fund were in 2017. Comparing to the other companies, this National Center for Research & Development performs on 19 percentage points less the average number of lead investments. The real fund results show that this Corporate Investor is 20 percentage points more often commits exit comparing to other companies. The common things for fund are deals in the range of 1 - 5 millions dollars. The fund is generally included in 2-6 deals every year.
The fund has no exact preference in some founders of portfolio startups. If startup sums 3 or 4 of the founder, the chance for it to be financed is low. Among the most successful fund investment fields, there are Artificial Intelligence, Software. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight APPLICA.AI, Billon Group, XTPL. For fund there is a match between the location of its establishment and the land of its numerous investments - Poland.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Cambrian Biopharma | New York, New York, United States |
| CPC & Partners | Canada, Ontario, Toronto |
| E3 Capital Partners | California, Los Angeles, United States |
| Galaxy Internet | Beijing, Beijing, China |
| Huahong Asset | Beijing, Beijing, China |
| Kateeva | California, Newark, United States |
| Nanyang Ventures | Australia, New South Wales, Sydney |
| Neev Fund | India, Maharashtra, Mumbai |
| Newegg | California, City Of Industry, United States |
| Palisades Technology Partners | Englewood Cliffs, New Jersey, United States |
| Parkview Ventures | New York, New York, United States |
| PWP Growth Equity | New York, New York, United States |
| Success Group | China, Foshan, Guangdong |
| Swarraton Partners | England, London, United Kingdom |
| The Melohn Group | - |
| University at Buffalo | Buffalo, New York, United States |
| University of Pittsburgh Innovation Institute | Pennsylvania, Pittsburgh, United States |
| Xinghao Venture Management Center | - |
| Xinyuan Investment | - |
| Xpanasia | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
BioCam | $1M | 30 Jun 2021 | Wroclaw, Lower Silesian Voivodeship, Poland | ||
Healthcann | $1M | 11 Feb 2021 | Wroclaw, Dolnoslaskie, Poland | ||
AILIS Breast Cancer Prediction Technology | $1M | 01 Dec 2020 | Kraków, Malopolskie, Poland | ||
Airly | $2M | 02 Oct 2020 | Krakow, Lesser Poland Voivodeship | ||
ICSEC | $1M | 31 Jan 2020 | Poznan, Wielkopolskie, Poland | ||
SmartLife Robotics | $260K | 31 Jul 2019 | Warsaw, Mazowieckie, Poland | ||
AILIS Breast Cancer Prediction Technology | $1M | 01 Jan 2018 | Kraków, Malopolskie, Poland | ||
FSE Fabryka Samochodów Elektrycznych Sp. z o.o. | $1M | 20 May 2017 | Bielsko-Biała, Silesian Voivodeship, Poland |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
BioCam | $1M | 30 Jun 2021 | Wroclaw, Lower Silesian Voivodeship, Poland | ||
Healthcann | $1M | 11 Feb 2021 | Wroclaw, Dolnoslaskie, Poland | ||
AILIS Breast Cancer Prediction Technology | $1M | 01 Dec 2020 | Kraków, Malopolskie, Poland | ||
Airly | $2M | 02 Oct 2020 | Krakow, Lesser Poland Voivodeship | ||
ICSEC | $1M | 31 Jan 2020 | Poznan, Wielkopolskie, Poland | ||
SmartLife Robotics | $260K | 31 Jul 2019 | Warsaw, Mazowieckie, Poland | ||
AILIS Breast Cancer Prediction Technology | $1M | 01 Jan 2018 | Kraków, Malopolskie, Poland | ||
FSE Fabryka Samochodów Elektrycznych Sp. z o.o. | $1M | 20 May 2017 | Bielsko-Biała, Silesian Voivodeship, Poland |
